Clinical Trial Results:
A 12-week, Phase-II, Double-Blind, Placebo-Controlled, Randomised,
Parallel-Group, Multi-Centre Study to Assess the Effect of 60 mg AZD9668
Administered Orally Twice Daily on Structural Changes in the Airways
by Multi-Slice Computed Tomography (MSCT) in Patients with Chronic
Obstructive Pulmonary Disease (COPD)
Summary
|
|
EudraCT number |
2009-014594-40 |
Trial protocol |
NL DK |
Global completion date |
17 Nov 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Oct 2016
|
First version publication date |
20 Oct 2016
|
Other versions |
|
Summary report(s) |
D0520C00014_results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.